Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metronidazole for BV in Labor
NCT03954990Phase 1Terminated
- Sponsor
- The University of Texas Medical Branch at Galveston
- Start
- Oct 2019
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of metronidazole in bacterial vaginosis (BV) (2 arms), sponsored by The University of Texas Medical Branch at Galveston. Primary endpoint: Rate of Composite outcome of maternal infections. Started Oct 2019; status: terminated.
02
Drugs
metronidazole
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on NCT03954990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03954990.